Christina M Marra Selected Research

Neurosyphilis (General Paresis of the Insane)

1/2021	Cognitive impairment in syphilis: Does treatment based on cerebrospinal fluid analysis improve outcome?
1/2021	A Dual-Platform Point-of-Care Test for Neurosyphilis Diagnosis.
11/2020	Neurosyphilis Treatment Outcomes After Intravenous Penicillin G Versus Intramuscular Procaine Penicillin Plus Oral Probenecid.
9/2017	Neurosyphilis Increases Human Immunodeficiency Virus (HIV)-associated Central Nervous System Inflammation but Does Not Explain Cognitive Impairment in HIV-infected Individuals With Syphilis.
12/2015	Neurosyphilis.
1/2015	Point-of-care treponemal tests for neurosyphilis diagnosis.
7/2014	Toll-like receptor polymorphisms are associated with increased neurosyphilis risk.
6/2012	The rapid plasma reagin test cannot replace the venereal disease research laboratory test for neurosyphilis diagnosis.
5/2010	CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis.
10/2008	Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christina M Marra Research Topics

Disease

14	Syphilis 01/2022 - 03/2004
13	Neurosyphilis (General Paresis of the Insane) 01/2021 - 02/2004
12	HIV Infections (HIV Infection) 05/2022 - 06/2003
11	Neurocognitive Disorders (Clerambault Syndrome) 06/2017 - 01/2011
6	Cognitive Dysfunction 01/2022 - 09/2007
5	Neuralgia (Stump Neuralgia) 01/2022 - 08/2006
5	Infections 01/2021 - 09/2002
5	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2021 - 04/2004
5	Progressive Multifocal Leukoencephalopathy 08/2009 - 09/2002
4	Inflammation (Inflammations) 05/2022 - 03/2015
4	Stroke (Strokes) 11/2021 - 05/2011
4	Acquired Immunodeficiency Syndrome (AIDS) 01/2019 - 09/2002
4	AIDS Dementia Complex 01/2010 - 06/2003
4	Multiple Sclerosis 08/2009 - 05/2006
3	Leukocytosis (Pleocytosis) 01/2021 - 05/2007
3	Dementia (Dementias) 04/2016 - 01/2011
2	Pain (Aches) 01/2022 - 01/2014
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 11/2015
2	Ischemic Stroke 11/2021 - 01/2021
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 01/2014
2	Neuroinflammatory Diseases 01/2020 - 01/2017
2	Central Nervous System Infections (Central Nervous System Infection) 01/2018 - 07/2011
2	Hearing Loss (Hearing Impairment) 01/2017 - 02/2006
2	Coinfection 04/2016 - 02/2014
2	Opportunistic Infections (Opportunistic Infection) 02/2014 - 02/2007
1	Polyneuropathies (Polyneuropathy) 01/2022
1	Premature Aging 01/2022
1	Thrombosis (Thrombus) 11/2021
1	Viremia 01/2021
1	Sepsis (Septicemia) 01/2021
1	Toxoplasmosis 01/2018
1	Encephalitis (Encephalitis, Rasmussen) 01/2018
1	Immune Reconstitution Inflammatory Syndrome 01/2018
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2018
1	Meningeal Tuberculosis (Tuberculous Meningitis) 01/2018

Drug/Important Bio-Agent (IBA)

8	RNA (Ribonucleic Acid)IBA 05/2022 - 05/2007
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2010
5	ReaginsIBA 04/2016 - 02/2004
4	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 05/2022 - 04/2004
4	Pharmaceutical PreparationsIBA 01/2021 - 11/2004
3	Lipopolysaccharide ReceptorsIBA 05/2022 - 03/2015
3	Interleukin-6 (Interleukin 6)IBA 05/2022 - 01/2017
3	Mitochondrial DNA (mtDNA)IBA 01/2022 - 11/2015
3	Choline (Choline Chloride)IBA 01/2020 - 06/2003
3	MacrolidesIBA 01/2019 - 12/2012
3	Azithromycin (Zithromax)FDA LinkGeneric 01/2019 - 12/2012
3	Memantine (Namenda)FDA Link 01/2010 - 08/2006
3	Natalizumab (Tysabri)FDA Link 02/2007 - 05/2006
2	Amyloid (Amyloid Fibrils)IBA 05/2022 - 01/2022
2	8-Hydroxy-2'-DeoxyguanosineIBA 05/2022 - 01/2022
2	C-Reactive ProteinIBA 05/2022 - 11/2021
2	Penicillin G (Benzylpenicillin)FDA LinkGeneric 11/2020 - 12/2015
2	IronIBA 01/2017 - 01/2014
2	Zidovudine (Retrovir)FDA LinkGeneric 04/2016 - 02/2006
2	Penicillin G Benzathine (Benzathine Benzylpenicillin)FDA Link 01/2016 - 03/2004
2	Ribosomal DNA (rDNA)IBA 01/2016 - 12/2012
2	FHDIBA 01/2016 - 01/2011
2	Cidofovir (Vistide)FDA Link 09/2008 - 09/2002
2	Protons (Proton)IBA 09/2007 - 01/2007
2	CreatineIBA 01/2007 - 06/2003
2	N-acetylaspartate (N-acetyl aspartate)IBA 01/2007 - 06/2003
2	Inositol (Myoinositol)IBA 01/2007 - 06/2003
1	Amyloid beta-PeptidesIBA 05/2022
1	CD40 Ligand (CD40L)IBA 05/2022
1	NeopterinIBA 05/2022
1	Antidepressive Agents (Antidepressants)IBA 05/2022
1	Type II Tumor Necrosis Factor ReceptorsIBA 05/2022
1	Monocyte Chemoattractant ProteinsIBA 05/2022
1	fibrin fragment D (D-dimer)IBA 05/2022
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2022
1	Amitriptyline (Elavil)FDA LinkGeneric 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	Angiopoietin-2IBA 11/2021
1	von Willebrand FactorIBA 11/2021
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 11/2021
1	PlasminogenIBA 11/2021
1	P-SelectinIBA 11/2021
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 11/2021
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 11/2021
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2021
1	Angiopoietin-1IBA 11/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Ribosomal RNAIBA 01/2021
1	Illicit Drugs (Recreational Drugs)IBA 01/2021
1	Cocaine (Cocaine HCl)IBA 01/2021
1	Probenecid (Benemid)FDA LinkGeneric 11/2020
1	Penicillin G Procaine (Procaine, Benzylpenicillin)FDA Link 11/2020
1	VaccinesIBA 01/2020
1	Inosine Monophosphate (IMP)IBA 01/2020
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	Ceruloplasmin (Ferroxidase)IBA 01/2017
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2017

Therapy/Procedure

19	Therapeutics 05/2022 - 06/2003
13	Highly Active Antiretroviral Therapy (HAART) 01/2018 - 09/2008
5	Aftercare (After-Treatment) 05/2011 - 03/2004
1	Pain Management 01/2022
1	Art Therapy 11/2021